Company Overview
Alto Ingredients, Inc. functions as a producer, distributor, and marketer of specialty alcohols, renewable fuel, and essential ingredients within the United States market. The company operates within the Basic Materials sector, specifically the Specialty Chemicals industry, a classification that denotes its focus on niche chemical compounds rather than bulk commodities. As a specialized entity in this space, the firm manages operations across three distinct segments: Marketing and Distribution, Pekin Campus Production, and Western Production. Alto Ingredients, Inc. currently holds a market capitalization of $338.76M and reports annual revenue of $917.93M while employing a workforce of 390 individuals. These valuation and revenue figures indicate that the company maintains a moderate scale within the specialty chemicals landscape, positioning it as a mid-cap player with significant operational reach but limited diversification compared to larger industrial conglomerates. The specific revenue magnitude suggests substantial sales volume relative to its market cap, highlighting a pricing structure where sales figures are several times larger than the equity value, which is a common characteristic in capital-intensive chemical distribution models.
Financial Health
The company reported total revenue of $917.93M over the trailing twelve months, generating net income of $12.07M and an EBITDA of $32.92M during the same period. The substantial disparity between the $917.93M revenue figure and the $12.07M net income reveals a cost structure characterized by high operating expenses, likely driven by manufacturing costs, distribution logistics, and the specific nature of specialty chemical production. Free cash flow stands at -$7,551,500, indicating a negative cash generation position that constrains the company's financial flexibility and limits its ability to fund expansion or pay down debt without external financing. Gross margin is recorded at 3.8%, operating margin at 3.6%, and profit margin at 1.5%, figures that collectively indicate a highly competitive industry environment where the company operates with thin profit buffers and significant pricing pressure. Cash reserves total $23.41M against total debt of $97.60M, resulting in a debt-to-equity ratio of 39.80, which suggests the balance sheet is leveraged rather than conservative given the debt load exceeds cash on hand by a factor of four. The current ratio of 2.64 indicates a healthy short-term liquidity position, demonstrating that the company possesses more than twice the current assets necessary to cover its current liabilities without immediate distress. Return on equity is 5.7% and return on assets is 1.2%, metrics that reveal management effectiveness is modest in converting capital into returns, particularly when asset efficiency is measured by the low ROA relative to the revenue base.
Valuation Assessment
Alto Ingredients, Inc. trades with a trailing P/E ratio of 27.38 and a forward P/E ratio of 12.51, a significant divergence that implies the market expects a sharp increase in earnings to align future valuations with current multiples. The price-to-book ratio is 1.38, indicating that the market values the company at a 38% premium over its net asset book value, which may reflect confidence in its intangible assets or future growth potential despite current profitability constraints. Alternative valuation metrics include a price-to-sales ratio of 0.37 and an EV/EBITDA of 12.54, suggesting that on a revenue basis the company is undervalued relative to peers, while the EV/EBITDA multiple reflects a debt-adjusted valuation that is moderate for a capital-intensive specialty chemical firm. The 52-week high is $4.89 and the 52-week low is $0.76, meaning the current trading price sits significantly below the recent peak, specifically trading well below the high mark established during the current fiscal year. The beta value of 0.67 indicates that the stock exhibits lower price volatility relative to the broader market, moving with less intensity than the overall index during periods of market fluctuation.
Growth & Income
Revenue growth year-over-year is -1.9%, while earnings growth year-over-year is listed as N/A, a situation where earnings data is insufficient to calculate a rate but implies earnings are not expanding at a pace that outpaces the slight revenue contraction. Since the company does not pay dividends, the dividend yield is N/A and the payout ratio is 0.0%, meaning the firm does not distribute cash to shareholders and instead retains all earnings to reinvest into growth or operational improvements. The overall growth and income profile is characterized by a lack of dividend income and a recent decline in top-line revenue, which suggests the company is currently in a phase of consolidation or adjustment rather than aggressive expansion or income generation. This profile indicates that shareholder returns are derived solely through capital appreciation potential rather than a consistent stream of dividend payments, requiring investors to rely on operational turnarounds to drive future stock performance.